Augmedix (NASDAQ:AUGX – Get Free Report) and Grab (NASDAQ:GRAB – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.
Profitability
This table compares Augmedix and Grab’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Augmedix | -41.95% | -178.34% | -38.74% |
| Grab | -11.86% | -4.62% | -3.48% |
Analyst Ratings
This is a summary of recent recommendations and price targets for Augmedix and Grab, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Augmedix | 0 | 4 | 0 | 0 | 2.00 |
| Grab | 0 | 0 | 9 | 0 | 3.00 |
Insider & Institutional Ownership
87.1% of Augmedix shares are owned by institutional investors. Comparatively, 55.5% of Grab shares are owned by institutional investors. 11.0% of Augmedix shares are owned by company insiders. Comparatively, 3.6% of Grab shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Volatility & Risk
Augmedix has a beta of -0.22, indicating that its share price is 122% less volatile than the S&P 500. Comparatively, Grab has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
Valuation and Earnings
This table compares Augmedix and Grab’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Augmedix | $51.58 million | 2.15 | -$19.17 million | ($0.43) | -5.28 |
| Grab | $2.49 billion | 5.00 | -$434.00 million | ($0.07) | -45.29 |
Augmedix has higher earnings, but lower revenue than Grab. Grab is trading at a lower price-to-earnings ratio than Augmedix, indicating that it is currently the more affordable of the two stocks.
Summary
Grab beats Augmedix on 10 of the 14 factors compared between the two stocks.
About Augmedix
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
About Grab
Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. The company offers its Grab ecosystem, a single platform with superapps for driver- and merchant-partners and consumers, that allows access to mobility, delivery, digital financial services, and enterprise sector offerings. Grab Holdings Limited is headquartered in Singapore.
Receive News & Ratings for Augmedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Augmedix and related companies with MarketBeat.com's FREE daily email newsletter.
